---
input_text: Bone loss is ameliorated by fecal microbiota transplantation through SCFA/GPR41/
  IGF1 pathway in sickle cell disease mice.Bone loss is common in sickle cell disease
  (SCD), but the molecular mechanisms is unclear. Serum insulin-like growth factor
  1 (IGF1) was low in SCD subjects and SCD mice. To determine if decreased IGF1 associated
  with low bone mass in SCD is due to reduced SCFA production by gut microbiota, we
  performed reciprocal fecal microbiota transplantation (FMT) between healthy control
  (Ctrl) and SCD mice. uCT and histomorphometry analysis of femur showed decreased
  bone volume/total volume (BV/TV), trabecular number (Tb.N), osteoblast surface/bone
  surface (Ob.S/BS), mineralizing surface/ bone surface (MS/BS), inter-label thickness
  (Ir.L.Th) in SCD mice were significantly improved after receiving Ctrl feces. Bone
  formation genes Alp, Col1, Runx2, and Dmp1 from SCD mice were significantly decreased
  and were rescued after FMT from Ctrl feces. Transplantation of Ctrl feces increased
  the butyrate, valerate, and propionate levels in cecal content of SCD mice. Decreased
  G-coupled protein receptors 41 and 43 (GPR41 and GPR43) mRNA in tibia and lower
  IGF1 in bone and serum of SCD mice were partially restored after FMT from Ctrl feces.
  These data indicate that the healthy gut microbiota of Ctrl mice is protective for
  SCD bone loss through regulating IGF1 in response to impaired bacterial metabolites
  SCFAs.
raw_completion_output: |-
  primary_disease: Sickle cell disease (SCD)

  medical_actions: Fecal microbiota transplantation (FMT); Serum insulin-like growth factor 1 (IGF1) measurement; uCT and histomorphometry analysis; Gene expression analysis

  symptoms: Decreased bone volume/total volume (BV/TV); Lower trabecular number (Tb.N); Reduced osteoblast surface/bone surface (Ob.S/BS); Decreased mineralizing surface/bone surface (MS/BS); Reduced inter-label thickness (Ir.L.Th); Low serum insulin-like growth factor 1 (IGF1)

  chemicals: Butyrate; Valerate; Propionate

  action_annotation_relationships: Fecal microbiota transplantation (FMT) TREATS decreased bone volume/total volume (BV/TV) IN Sickle cell disease (SCD); Fecal microbiota transplantation (FMT) TREATS lower trabecular number (Tb.N) IN Sickle cell disease (SCD); Fecal microbiota transplantation (FMT) TREATS reduced osteoblast surface/bone surface (Ob.S/BS) IN Sickle cell disease (SCD); Fecal microbiota transplantation (FMT) TREATS decreased mineralizing surface/bone surface (MS/BS) IN Sickle cell disease (SCD); Fecal microbiota transplantation (FMT) TREATS reduced inter-label thickness (Ir.L.Th) IN Sickle cell disease (SCD); Fecal microbiota transplantation (FMT) TREATS low serum insulin-like growth factor 1 (IGF1) IN Sickle cell disease (SCD); Fecal microbiota transplantation (FMT) with butyrate TREATS Sickle cell disease (SCD); Fecal microbiota transplantation (FMT) with valerate TREATS Sickle cell disease (SCD); Fecal microbiota transplantation (FMT) with propionate TREATS Sickle cell disease (SCD)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Fecal microbiota transplantation (FMT) with propionate TREATS Sickle cell disease (SCD)

  ===

extracted_object:
  primary_disease: MONDO:0007374
  medical_actions:
    - MAXO:0000748
    - Serum insulin-like growth factor 1 (IGF1) measurement
    - uCT and histomorphometry analysis
    - Gene expression analysis
  symptoms:
    - Decreased bone volume/total volume (BV/TV)
    - Lower trabecular number (Tb.N)
    - Reduced osteoblast surface/bone surface (Ob.S/BS)
    - Decreased mineralizing surface/bone surface (MS/BS)
    - Reduced inter-label thickness (Ir.L.Th)
    - Low serum insulin-like growth factor 1 (IGF1)
  chemicals:
    - CHEBI:17968
    - CHEBI:31011
    - CHEBI:17272
  action_annotation_relationships:
    - subject: MAXO:0000748
      predicate: TREATS
      object: decreased bone volume/total volume (BV/TV)
      qualifier: MONDO:0011382
    - subject: MAXO:0000748
      predicate: TREATS
      object: lower trabecular number
      qualifier: MONDO:0011382
      subject_extension: Fecal microbiota transplantation
    - subject: MAXO:0000748
      predicate: <TREATS>
      object: <reduced osteoblast surface/bone surface (Ob.S/BS)>
      qualifier: MONDO:0007374
      subject_extension: <Fecal microbiota>
    - subject: MAXO:0000748
      predicate: TREATS
      object: decreased mineralizing surface/bone surface (MS/BS)
      qualifier: MONDO:0011382
    - subject: <Fecal microbiota transplantation>
      predicate: <TREATS>
      object: <reduced inter-label thickness>
      qualifier: <Sickle cell disease>
      subject_extension: <Fecal microbiota transplantation>
    - subject: <Fecal microbiota transplantation>
      predicate: <TREATS>
      object: <low serum insulin-like growth factor 1>
      qualifier: <Sickle cell disease>
      subject_qualifier: <>
      object_qualifier: <>
      subject_extension: <Fecal microbiota>
      object_extension: <insulin-like growth factor 1>
    - subject: MAXO:0000748
      predicate: TREATS
      object: Sickle cell disease
      qualifier: MONDO:0007374
      subject_extension: CHEBI:17968
    - subject: MAXO:0000748
      predicate: TREATS
      object: Sickle cell disease
      qualifier: MONDO:0007374
      subject_extension: CHEBI:31011
    - subject: MAXO:0000748
      predicate: TREATS
      object: Sickle cell disease
      qualifier: MONDO:0007374
      subject_extension: CHEBI:17272
named_entities:
  - id: MONDO:0011382
    label: Sickle Cell Anemia
  - id: MONDO:0007374
    label: Sickle cell disease (SCD)
  - id: MAXO:0000747
    label: Allogeneic hematopoietic stem cell transplantation (HSCT)
  - id: MAXO:0000756
    label: blood transfusion
  - id: CHEBI:33281
    label: antibiotics
  - id: HP:0001944
    label: dehydration
  - id: HP:0007760
    label: Sickle Cell Disease (SCD) symptoms
  - id: HP:0012592
    label: Albuminuria
  - id: HP:0012622
    label: Chronic kidney disease
  - id: HP:0100543
    label: cognitive deficits
  - id: MAXO:0001001
    label: Gene therapy
  - id: HP:0002863
    label: myelodysplastic syndrome
  - id: HP:0004808
    label: acute myeloid leukemia
  - id: CHEBI:28901
    label: busulfan
  - id: HP:0010972
    label: Ineffective erythropoiesis
  - id: HP:0001878
    label: Hemolytic anemia
  - id: HP:0001903
    label: Anemia
  - id: CHEBI:35143
    label: Hemoglobin (HbS)
  - id: CHEBI:44423
    label: hydroxycarbamide
  - id: MONDO:0020380
    label: Sickle cell anemia (SCA)
  - id: MONDO:0002120
    label: Nasopharyngeal neuroendocrine carcinoma (NEC)
  - id: HP:0030828
    label: wheeze
  - id: HP:0012735
    label: cough
  - id: MONDO:0003664
    label: Haemolytic anaemias
  - id: HP:0032654
    label: Endothelial dysfunction
  - id: HP:0025464
    label: Oxidative stress
  - id: CHEBI:17627
    label: Haem
  - id: CHEBI:18248
    label: Iron
  - id: CHEBI:197439
    label: TNFalpha
  - id: MAXO:0000149
    label: haploidentical hematopoietic cell transplant (HCT)
  - id: MONDO:0005570
    label: Blood disorders
  - id: HP:0002617
    label: Vasculopathy
  - id: HP:0010885
    label: Bone infarctions
  - id: MONDO:0013517
    label: beta-thalassemia
  - id: HP:0001945
    label: fever
  - id: HP:0033050
    label: sore throat
  - id: HP:0002315
    label: headache
  - id: HP:0001394
    label: Cirrhosis
  - id: HP:0002204
    label: Pulmonary embolus
  - id: HP:0001297
    label: Stroke
  - id: HP:0031033
    label: Renal acidification defect
  - id: HP:0032632
    label: Renal papillary necrosis
  - id: HP:0000093
    label: Proteinuria
  - id: HP:0003774
    label: End-stage renal disease
  - id: HP:0012213
    label: Decreased glomerular filtration rate (GFR)
  - id: CHEBI:59163
    label: biomarkers
  - id: MAXO:0000915
    label: Standardized polysomnography (PSG)
  - id: HP:0002360
    label: Sleep disturbances
  - id: HP:0034312
    label: Nocturnal hypoxemia
  - id: CHEBI:35482
    label: opioid analgesics
  - id: MONDO:0005148
    label: type II diabetes
  - id: MAXO:0000058
    label: Pharmacotherapy
  - id: MAXO:0000457
    label: Pain management
  - id: CHEBI:18050
    label: L-glutamine
  - id: HP:0004421
    label: Elevated systolic blood pressure
  - id: HP:0030515
    label: Moderate visual impairment
  - id: HP:0000618
    label: Blindness
  - id: CHEBI:68579
    label: rivaroxaban
  - id: CHEBI:24261
    label: glucocorticoids
  - id: HP:0012532
    label: Chronic pain
  - id: CHEBI:6121
    label: Ketamine
  - id: MONDO:0010631
    label: Acute ischemic priapism (IP)
  - id: CHEBI:8093
    label: Phenylephrine
  - id: CHEBI:35480
    label: Analgesics
  - id: CHEBI:35705
    label: immunosuppressive agents
  - id: MAXO:0000503
    label: Mechanical ventilation
  - id: CHEBI:25555
    label: Nitrogen
  - id: HP:0001396
    label: Cholestasis
  - id: HP:0000083
    label: Kidney failure
  - id: CHEBI:50858
    label: Corticosteroids
  - id: CHEBI:9570
    label: thiotepa
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: MAXO:0000494
    label: Blood pressure monitoring
  - id: HP:0003006
    label: lack of universal newborn screening (NBS)
  - id: MONDO:0002049
    label: Thrombocytopenia
  - id: MAXO:0001017
    label: vaccination
  - id: HP:0001873
    label: Thrombocytopenia
  - id: MONDO:0100096
    label: COVID-19
  - id: CHEBI:46195
    label: Acetaminophen
  - id: CHEBI:47381
    label: Diclofenac
  - id: MAXO:0000861
    label: Labor induction
  - id: HP:0100602
    label: Preeclampsia
  - id: CHEBI:16199
    label: Urea
  - id: CHEBI:16737
    label: Creatinine
  - id: MAXO:0000748
    label: Fecal microbiota transplantation (FMT)
  - id: CHEBI:17968
    label: Butyrate
  - id: CHEBI:31011
    label: Valerate
  - id: CHEBI:17272
    label: Propionate
